首页> 外文期刊>EFSA Journal >Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐UK‐2006‐34) for authorisation of food and feed containing, consisting of and produced from genetically modified maize 3272
【24h】

Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐UK‐2006‐34) for authorisation of food and feed containing, consisting of and produced from genetically modified maize 3272

机译:补充欧洲食品安全局科学意见申请书(EFSA-GMO-UK-2006-34)的声明,授权使用含有转基因玉米的食品和饲料3272

获取原文
           

摘要

Following a request from the European Commission, the GMO Panel assessed additional information related to the application for authorisation of food and feed containing, consisting of and produced from genetically modified (GM) maize 3272 (EFSA‐GMO‐UK‐2006‐34). The applicant conducted new agronomic, phenotypic and compositional analysis studies on maize 3272 and assessed the allergenic potential of AMY797E protein, addressing elements that remained inconclusive from previous EFSA opinion issued in 2013. The GMO Panel is of the opinion that the agronomic and phenotypic characteristics as well as forage and grain composition of maize 3272 do not give rise to food and feed safety, and nutritional concerns when compared to non‐GM maize. Considering the scope of this application and the characteristics of the trait introduced in this GM maize, the effect of processing and potential safety implications of specific food or feed products remain to be further investigated. Regarding the allergenic potential of AMY797E protein and considering all possible food and feed uses of maize 3272, the Panel concludes that the information provided does not fully address the concerns previously raised by the Panel in 2013. Owing to the nature and the knowledge available on this protein family, it is still unclear whether under specific circumstances the alpha‐amylase AMY797E has the capacity to sensitise certain individuals and to cause adverse effects. To further support the safety of specific products of maize 3272, the applicant provided thorough information relevant for the allergenicity assessment of dried distiller grains with solubles (DDGS), which is the main product of interest for importation into the EU. Having considered the information provided on this product, the Panel is of the opinion that under the specific conditions of use described by the applicant, DDGS produced from maize 3272 does not raise concerns when compared to DDGS from non‐GM maize.
机译:应欧盟委员会的要求,GMO小组评估了与授权申请的食品和饲料相关的其他信息,这些食品包含由转基因玉米3272构成,由其生产和生产的食品(EFSA-GMO-UK-2006-34)。申请人在玉米3272上进行了新的农艺,表型和组成分析研究,并评估了AMY797E蛋白的变应原潜力,解决了先前在2013年发布的EFSA意见中尚无定论的要素。GMO专家组认为,农艺和表型特征为与非转基因玉米相比,玉米3272的草料和谷粒组成不会引起食品和饲料安全以及营养方面的问题。考虑到本申请的范围和在此转基因玉米中引入的性状的特征,特定食品或饲料产品的加工效果和潜在的安全隐患仍有待进一步研究。关于AMY797E蛋白的致敏潜力,并考虑到玉米3272的所有可能的食品和饲料用途,小组得出的结论是,所提供的信息并未完全解决小组先前在2013年提出的关注。由于该问题的性质和知识蛋白家族,尚不清楚在特定情况下,α-淀粉酶AMY797E是否具有使某些个体敏感并引起不良反应的能力。为了进一步支持3272玉米特定产品的安全性,申请人提供了与可溶性干酒糟(DDGS)的致敏性评估有关的详尽信息,DDGS是进口到欧盟的主要产品。在考虑了有关该产品的信息之后,小组认为,在申请人描述的特定使用条件下,与非转基因玉米的DDGS相比,玉米3272生产的DDGS不会引起关注。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号